Key result
Comorbidity of clinical atherosclerotic vascular disease and higher pre-peritonitis hsCRP were independent risk factors for poor short-term outcomes in PDAP.
Why the study?
Do higher pre-peritonitis hsCRP and comorbidity of clinical atherosclerotic vascular disease predict poor short-term outcomes in patients with peritoneal dialysis-associated peritonitis?
Observational
Do higher pre-peritonitis hsCRP and comorbidity of clinical atherosclerotic vascular disease predict poor short-term outcomes in patients with peritoneal dialysis-associated peritonitis?
Higher pre-peritonitis hsCRP and baseline clinical atherosclerotic vascular disease are independent predictors of short-term poor outcomes in patients with peritoneal dialysis-associated peritonitis.
Answers are grounded in this paper and cite their sources.
May aid short-term risk stratification in PDAP; hypothesis-generating and requires prospective validation before guiding care.
);Z=-2.084,P=0.037] were observed in poor outcome group. Univariate Logistic regression analysis showed the combination of clinical atherosclerotic vascular disease (OR=2.070,95%CI:1.062-4.034,P=0.033) and higher hsCRP before peritonitis (OR=1.032,95%CI:1.001-1.059,P=0.015) were the risk factors of short-term poor outcome in PDAP patients. Multivariate Logistic regression analysis showed that,after the gender,age at peritonitis,PD duration,diabetes,and serum albumin before peritonitis were adjusted,higher hsCRP before peritonitis (OR=1.026,95%CI:1.000-1.052,P=0.046) and comorbidity of clinical atherosclerotic vascular disease (OR=2.105,95% CI:1.014-4.367,P=0.046) were the independent risk factors for the poor outcomes in PDAP patients. Conclusion Higher pre-peritonitis hsCRP and comorbidity of clinical atherosclerotic vascular disease at baseline may predict poor short-term outcomes in PDAP patients.
No takes yet. Share an insight, caveat, or question.
Ma et al. (2018) conducted an observational in Peritoneal Dialysis-associated Peritonitis (PDAP). Clinical atherosclerotic vascular disease and higher pre-peritonitis hsCRP vs. Absence of these risk factors was evaluated on Short-term poor outcome (OR 2.105, 95% CI 1.014-4.367, p=0.046). Comorbidity of clinical atherosclerotic vascular disease and higher pre-peritonitis hsCRP were independent risk factors for poor short-term outcomes in PDAP.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: